BIALX
Price
$30.12
Change
+$0.26 (+0.87%)
Updated
Sep 4 closing price
Net Assets
2.47B
CNPAX
Price
$70.65
Change
+$0.34 (+0.48%)
Updated
Sep 5 closing price
Net Assets
159.21B
Interact to see
Advertisement

BIALX vs CNPAX

Header iconBIALX vs CNPAX Comparison
Open Charts BIALX vs CNPAXBanner chart's image
Brown Advisory Global Leaders Investor
Price$30.12
Change+$0.26 (+0.87%)
VolumeN/A
Net Assets2.47B
American Funds New Perspective 529A
Price$70.65
Change+$0.34 (+0.48%)
VolumeN/A
Net Assets159.21B
BIALX vs CNPAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BIALX vs. CNPAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIALX is a Buy and CNPAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 159B vs. BIALX (2.47B). CNPAX pays higher dividends than BIALX: CNPAX (0.48) vs BIALX (0.33). BIALX was incepted earlier than CNPAX: BIALX (10 years) vs CNPAX (24 years). BIALX (0.91) is less costly to investors than CNPAX (0.77). CNPAX is a more actively managed with annual turnover of: 24.00 vs. BIALX (15.00). BIALX has a lower initial minimum investment than CNPAX: BIALX (100) vs CNPAX (250). CNPAX (15.09) and BIALX (14.53) have marching annual gain over last year. BIALX return over 5 years is better than : 68.43 vs. CNPAX (36.01).
BIALXCNPAXBIALX / CNPAX
Total Expense Ratio0.910.77118%
Annual Report Gross Expense Ratio0.910.77118%
Fund Existence10 years24 years-
Gain YTD12.37415.76379%
Front LoadN/A4%-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets2.47B159B2%
Annual Yield % from dividends0.330.4869%
Returns for 1 year14.5315.0996%
Returns for 3 years65.1949.57132%
Returns for 5 years68.4336.01190%
Returns for 10 years220.65106.66207%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX19.440.17
+0.88%
Saratoga Health & Biotechnology A
BHSRX57.770.28
+0.49%
BlackRock Health Sciences Opps R
GOFCX27.580.09
+0.33%
Victory Pioneer Select Mid Cap Growth C
RPMFX16.550.02
+0.12%
Reinhart Genesis PMV Advisor
ETLNX15.560.01
+0.06%
Eventide Large Cap Focus N